Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation

Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation

Objectives: This study aimed to investigate the role of serum levels of transient receptor potential cation channel subfamily V member 1 (TRPV1), vasoacive intestinal peptide (VIP), and pituitary adenylate cyclase-activating polypeptide (PACAP) in the development and also the transformation of migra...

Full description

Bibliographic Details
Main Authors:	Mansoureh Togha, Zeinab Ghorbani, Samira Ramazi, Fahime Zavvari, Fariba Karimzadeh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Neurology
Subjects:	TRPV1 VIP PACAP migraine migraine transformation
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2021.770980/full

Similar Items

Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
by: Faisal Mohammad Amin, et al.
Published: (2018-05-01)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
by: Lucia Ciranna, et al.
Published: (2021-09-01)

Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study
by: Anne Marie Lund, et al.
Published: (2022-10-01)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
by: Casper Emil Christensen, et al.
Published: (2022-09-01)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
by: Gabriella Horvath, et al.
Published: (2022-04-01)

Increased serum prolactin level may indicate more migraine attack frequency
by: Mansoureh Togha, et al.
Published: (2023-07-01)

Shared and independent roles of CGRP and PACAP in migraine pathophysiology
by: Adisa Kuburas, et al.
Published: (2023-04-01)

Role of PACAP in migraine: An alternative to CGRP?
by: Song Guo, et al.
Published: (2023-01-01)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
by: Christina Deligianni, et al.
Published: (2023-04-01)

Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
by: Robert Gábriel, et al.
Published: (2019-10-01)

Immunohistochemical Study on the Innervation of the Chicken Pancreas by Pituitary Adenylate Cyclase-Activating Polypeptides (PACAPs)-Containing Nerves
by: Kohzy Hiramatsu, et al.
Published: (2009-07-01)

Sex-related differences in endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) in the thalamic paraventricular nucleus: Implications for addiction neuroscience
by: Genevieve R. Curtis, et al.
Published: (2023-03-01)

Migraines /
by: Williams, Mary E., 1960-, editor 454454, et al.
Published: (2011)

The effect of orofacial complete Freund’s adjuvant treatment on the expression of migraine-related molecules
by: Tamás Körtési, et al.
Published: (2019-04-01)

The Impact of Aging on Brain Pituitary Adenylate Cyclase Activating Polypeptide, Pathology and Cognition in Mice and Rhesus Macaques
by: Pengcheng Han, et al.
Published: (2017-06-01)

Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study
by: Gaia Pellitteri, et al.
Published: (2022-05-01)

Migraine Treatment: Towards New Pharmacological Targets
by: Marcello Silvestro, et al.
Published: (2023-07-01)

A Broad Overview on Pituitary Adenylate Cyclase-Activating Polypeptide Role in the Eye: Focus on Its Repairing Effect in Cornea
by: Grazia Maugeri, et al.
Published: (2022-01-01)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
by: Levente Czegledi, et al.
Published: (2022-06-01)

Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro
by: Tibor Hajdú, et al.
Published: (2021-09-01)

Involvement of Vasoactive Intestinal Peptide Family Members in Diabetic Keratopathy
by: Grazia Maugeri, et al.
Published: (2024-02-01)

Molecular and Cellular Neurobiology of Circadian and Circannual Rhythms in Migraine: A Narrative Review
by: Noboru Imai
Published: (2023-06-01)

PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
by: Song Guo, et al.
Published: (2022-12-01)

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma
by: Evelin Patko, et al.
Published: (2023-08-01)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review
by: Aleksandra Karpiesiuk, et al.
Published: (2021-08-01)

The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli
by: Daniel Porta-Casteràs, et al.
Published: (2022-05-01)

Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease
by: Takahiro Hirabayashi, et al.
Published: (2022-01-01)

Presence of Systemic Amyloidosis in Mice with Partial Deficiency in Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Aging
by: Jason Sparks, et al.
Published: (2021-08-01)

Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats
by: Laszlo Adam Fazekas, et al.
Published: (2023-11-01)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
by: Dénes Tóth, et al.
Published: (2023-10-01)

New Evidence for the Role of Pituitary Adenylate Cyclase-Activating Polypeptide as an Antimicrobial Peptide in Teleost Fish
by: Janet Velázquez, et al.
Published: (2023-09-01)

Vestibular migraine
by: Santosh Kumar Swain, et al.
Published: (2021-01-01)

Current Perspective on Retinal Migraine
by: Yu Jeat Chong, et al.
Published: (2021-08-01)

Diabetes Affects the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Like Immunoreactive Enteric Neurons in the Porcine Digestive Tract
by: Katarzyna Palus, et al.
Published: (2021-05-01)

TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
by: Eleonóra Spekker, et al.
Published: (2022-12-01)

Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Treatment during Pre-maturation Increases the Maturation of Porcine Oocytes Derived from Small Follicles
by: Kyu-Mi Park, et al.
Published: (2018-03-01)

Comparison of Audiological Findings in Patients with Vestibular Migraine and Migraine
by: Günay Kırkım, et al.
Published: (2017-12-01)

Protective effects of PACAP in ischemia
by: Dora Reglodi, et al.
Published: (2018-03-01)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
by: Simona Sacco, et al.
Published: (2021-05-01)

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors
by: Yuji Kaneko, et al.
Published: (2018-12-01)